These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Novel aspects of angiotensin II action in the heart. Implications to myocardial ischemia and heart failure. De Mello WC Regul Pept; 2011 Jan; 166(1-3):9-14. PubMed ID: 20934462 [TBL] [Abstract][Full Text] [Related]
4. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Zhou N; Li L; Wu J; Gong H; Niu Y; Sun A; Ge J; Zou Y Biochem Biophys Res Commun; 2010 Jun; 397(2):263-9. PubMed ID: 20580688 [TBL] [Abstract][Full Text] [Related]
5. Anti-stress and anti-anxiety effects of centrally acting angiotensin II AT1 receptor antagonists. Saavedra JM; Ando H; Armando I; Baiardi G; Bregonzio C; Juorio A; Macova M Regul Pept; 2005 Jun; 128(3):227-38. PubMed ID: 15837532 [TBL] [Abstract][Full Text] [Related]
6. Negative regulation of VEGF-induced vascular leakage by blockade of angiotensin II type 1 receptor. Sano H; Hosokawa K; Kidoya H; Takakura N Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2673-80. PubMed ID: 16973968 [TBL] [Abstract][Full Text] [Related]
7. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart. Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903 [TBL] [Abstract][Full Text] [Related]
8. [Hypertrophic responses to mechanical stretch in cardiac myocytes]. Yamazaki T; Komuro I; Yazaki Y Tanpakushitsu Kakusan Koso; 1996 Jan; 41(1):14-8. PubMed ID: 8584736 [No Abstract] [Full Text] [Related]
9. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Jaffe IZ; Mendelsohn ME Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497 [TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias. Garg S; Narula J; Marelli C; Cesario D Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603 [TBL] [Abstract][Full Text] [Related]
11. The 'double dip' hypothesis: simultaneous prevention of cardiovascular and pulmonary morbidity and mortality using angiotensin II type 1 receptor blockers. Mancini GB Can J Cardiol; 2005 May; 21(6):519-23. PubMed ID: 15917881 [TBL] [Abstract][Full Text] [Related]
12. An angiotensin II receptor blocker increases sexual behavior in type 2 diabetic mice. Nomura M; Nishii H; Ozaki Y; Fujimoto N; Matsumoto T Physiol Behav; 2007 Jun; 91(2-3):223-8. PubMed ID: 17434545 [TBL] [Abstract][Full Text] [Related]
14. [Involvement of angiotensin II in pathogenesis of hypertension and target organ damage]. Okigaki M; Iwasaka T Nihon Rinsho; 2004 Mar; 62 Suppl 3():139-43. PubMed ID: 15171357 [No Abstract] [Full Text] [Related]
15. Delineating the contributions of AT1a and AT1b receptor-mediated uptake of ANG II in kidneys and adrenals. Ortiz RM Am J Physiol Renal Physiol; 2008 Feb; 294(2):F291-2. PubMed ID: 18077595 [No Abstract] [Full Text] [Related]
16. [Regulatory mechanisms of cardiovascular remodeling in hypertension]. Kurabayashi M Nihon Rinsho; 2006 Jul; 64 Suppl 5():221-8. PubMed ID: 16895188 [No Abstract] [Full Text] [Related]
17. The role of angiotensin II in stress urinary incontinence: A rat model. Phull H; Salkini M; Escobar C; Purves T; Comiter CV Neurourol Urodyn; 2007; 26(1):81-8; discussion 89. PubMed ID: 17029249 [TBL] [Abstract][Full Text] [Related]
18. Lack of heterologous receptor desensitization induced by angiotensin II type 1 receptor activation in isolated normal rat thoracic aorta. Pérez T; López RM; López P; Castillo C; Castillo EF Vascul Pharmacol; 2011; 54(1-2):29-35. PubMed ID: 21122823 [TBL] [Abstract][Full Text] [Related]
19. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone. Miceli I; Burt D; Tarabra E; Camussi G; Perin PC; Gruden G Am J Physiol Renal Physiol; 2010 Feb; 298(2):F381-90. PubMed ID: 19906946 [TBL] [Abstract][Full Text] [Related]
20. [Diversity in mechanism of angiotensin II production and application of the suppressive agents]. Miyazaki T Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):178-9. PubMed ID: 18421843 [No Abstract] [Full Text] [Related] [Next] [New Search]